富耀生醫創投有限合夥
forwardasset.com.tw Direct investor
安瑞管理顧問 manages the 富耀生醫創投有限合夥 fund, which invests in specialty drug developers, animal health biotech companies and biopharma service providers. The team also works with Taiwanese CDMO and pharmaceutical manufacturers to support portfolio companies.
富耀生醫創投有限合夥 is a venture capital firm headquartered in Taipei, Taiwan. It invests directly in companies, in 特色藥品開發, 動物保健生技 and 生技醫藥服務. 新台幣8.92億元 under management and 8 portfolio companies, as it reports.
“目前管理「富耀生醫創投有限合夥」基金，資產規模約為新台幣8.92億元，專注投資於技術已驗證的特色藥品開發公司、動物保健生技公司與生技醫藥服務業者等。”
— 富耀生醫創投有限合夥, own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Invests in
- Taiwan
- Sectors
- 特色藥品開發, 動物保健生技, 生技醫藥服務
- Assets under management
- 新台幣8.92億元
- Portfolio
- 8 companies
Team, as 富耀生醫創投有限合夥 publishes it
- 鍾威廉 董事長暨總經理
- 林晉源 策略長暨合夥人
- 黃建達 合夥人
- 鍾昌杰 合夥人
Names and roles exactly as listed on forwardasset.com.tw. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page 富耀生醫創投有限合夥 publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://forwardasset.com.tw/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, sectors, thesis_quote, description, aum, portfolio_count, status
- https://forwardasset.com.tw/meet-our-team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 16346 · added 2026-10-26 · link last verified 2026-10-26 · confidence high
Similar investors
- AppWorksVenture capital · Seed – Series C+ · Taipei, Taiwan
- B Current Impact InvestmentVenture capital · Taipei, Taiwan
- BE HealthVenture capital · Pre-seed – Series B · Taipei, Taiwan
- Comma3 VenturesVenture capital · Seed – Series A · Taipei, Taiwan
- Concord Venture Capital GroupVenture capital · Taipei, Taiwan
- Darwin Venture ManagementVenture capital · Pre-seed – Growth · Taipei, Taiwan